On June 24, 2026, the Investigations and Oversight Subcommittee of the U.S. House of Representatives Committee on Science, Space, and Technology held a hearing on “Federal Research Funds: The False Claims Act’s Role in Combating Grant Fraud.” Brenna Jenny, DOJ’s Deputy Assistant Attorney General for Commercial Litigation, testified on three FCA enforcement “focus areas” related
Latest Post
More Posts
Challenging Executive Order on DEI, States Say It Gets FCA Materiality Wrong
DOJ Announces FOCUS Initiative to Work with Data Miners Filing Qui Tams
DOJ Announces First FCA Settlement Resolving Title VII Discrimination Allegations
Strictly Enforcing Rule 9(b), Second Circuit Affirms Dismissal of FCA Claim Based on Allegedly Defective Medical Devices
Court Grants Motion to Dismiss FCA Claim for Failure Adequately to Plead Scienter
DAAG Jenny Reinforces Commitment to FCA Enforcement Premised on “Unlawful DEI”
First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical Labs
First Circuit Affirms Dismissal of Qui Tam for Failing But-For Test Linking AKS Violations to FCA Liability
DOJ Announces Reinvigorated False Claims Act Cooperation with the Department of Health and Human Services
Subscribe: Subscribe via RSS
Blogs
Firm/Org